Bromelain Proteinase Activity in IBD
Bromelain Proteinase Activity in IBD
批准号:
7046140
负责人:
Laura P. Hale
金额:
$17.37万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-04-01 至 2008-03-31
关键词:
alternative medicineantiinflammatory agentsbiopsychemokinecolitiscysteine endopeptidasesdisease /disorder modeldrug quality /standardenzyme activitygastrointestinal disorder chemotherapygenetically modified animalsimmunocytochemistryinflammationinflammatory bowel diseaseslaboratory mouseleukocyte activation /transformationmedicinal plantsnonhuman therapy evaluationpharmacokineticsplant extractsprotein purificationproteolysiswestern blottings
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Bromelain is a mixture of proteinases derived from pineapple stem that is sold in health food stores as a "digestive aid". Beneficial therapeutic effects of bromelain have also been suggested or proven in several human inflammatory diseases and animal models of inflammation. Self-treatment with oral bromelain induced clinical and endoscopic remission of ulcerative colitis in two patients whose disease was refractory to conventional multi-agent medical therapy. Our controlled animal studies show that bromelain treatment decreases both the development of spontaneous colitis and the severity of established colitis in the IL-10 knockout (IL-10 -/-) murine model of inflammatory bowel disease (IBD). The biological effects of bromelain appear to depend on its proteolytic activity, which can vary from lot to lot according to its proteinase composition. It is critical that the bromelain to be used in human trials contain appropriate levels of active ingredients. However, it is not currently known which proteinases within bromelain account for its anti-inflammatory activity in IBD. We have developed assays to specifically measure the proteolytic activity of the 3 major bromelain proteinases (stem bromelain, ananain, and fruit bromelain) as well as procedures to purify these enzymes. In this study, IL-10-/- mice with established colitis will be treated orally with purified
bromelain proteinases and effects on colonic inflammation will be determined. The proposed studies will definitively determine how the 3 major bromelain proteinases contribute to anti-inflammatory effects of bromelain within the colon. They will also begin to determine the mechanisms by which this occurs. This information will facilitate further investigations of the mechanisms involved as well as the rational design of future clinical trials of this promising complementary colitis therapy. They will thus strengthen the scientific knowledge base needed to inform the practice of complementary and alternative medicine.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
catena-Poly[[diaqua-nickel(II)]-bis-(μ-pyridine-4-sulfinato)-κN,O;κO,N].
链状聚[[diaqua-镍(II)]-双-(μ-吡啶-4-亚磺基)-μN,O;μO,N]。
DOI:
10.1107/s1600536809024258
发表时间:
2009
期刊:
Acta crystallographica. Section E, Structure reports online
影响因子:
--
作者:
[Du,Zhong-Xiang, Ji,Su-Ning]
通讯作者:
Ji,Su-Ning
Core C: Human Thymus Core
-
批准号:10251296
-
项目类别:
-
资助金额:$36.59万
-
财政年份:2020
-
负责人:Laura P. Hale
-
依托单位:
Core C: Human Thymus Core
-
批准号:10689280
-
项目类别:
-
资助金额:$48.93万
-
财政年份:2020
-
负责人:Laura P. Hale
-
依托单位:
Core C: Human Thymus Core
-
批准号:10022936
-
项目类别:
-
资助金额:$38.1万
-
财政年份:2020
-
负责人:Laura P. Hale
-
依托单位:
Core C: Human Thymus Core
-
批准号:10470929
-
项目类别:
-
资助金额:$36.55万
-
财政年份:2020
-
负责人:Laura P. Hale
-
依托单位:
Human Target Verification and Thymic Function Core
-
批准号:10553991
-
项目类别:
-
资助金额:$18.32万
-
财政年份:2017
-
负责人:Laura P. Hale
-
依托单位:
Mechanisms Underlying Colorectal Cancer Risk in IBD (PQ6)
-
批准号:8543669
-
项目类别:
-
资助金额:$16.05万
-
财政年份:2012
-
负责人:Laura P. Hale
-
依托单位:
Mechanisms Underlying Colorectal Cancer Risk in IBD (PQ6)
-
批准号:8370935
-
项目类别:
-
资助金额:$20.49万
-
财政年份:2012
-
负责人:Laura P. Hale
-
依托单位:
Mast Cells and IBD Pathogenesis
-
批准号:7128496
-
项目类别:
-
资助金额:$23.33万
-
财政年份:2006
-
负责人:Laura P. Hale
-
依托单位:
Chemoprevention of IBD-Associated Colon Cancer
-
批准号:7195393
-
项目类别:
-
资助金额:$24.85万
-
财政年份:2006
-
负责人:Laura P. Hale
-
依托单位:
Chemoprevention of IBD-Associated Colon Cancer
-
批准号:7669205
-
项目类别:
-
资助金额:$24.2万
-
财政年份:2006
-
负责人:Laura P. Hale
-
依托单位:
Chemoprevention of IBD-Associated Colon Cancer
-
批准号:7897692
-
项目类别:
-
资助金额:$24.2万
-
财政年份:2006
-
负责人:Laura P. Hale
-
依托单位:
Chemoprevention of IBD-Associated Colon Cancer
-
批准号:7496973
-
项目类别:
-
资助金额:$24.2万
-
财政年份:2006
-
负责人:Laura P. Hale
-
依托单位:
Mast Cells and IBD Pathogenesis
-
批准号:7282740
-
项目类别:
-
资助金额:$18.93万
-
财政年份:2006
-
负责人:Laura P. Hale
-
依托单位:
Chemoprevention of IBD-Associated Colon Cancer
-
批准号:7295950
-
项目类别:
-
资助金额:$24.2万
-
财政年份:2006
-
负责人:Laura P. Hale
-
依托单位:
Bromelain Proteinase Activity in IBD
-
批准号:6898569
-
项目类别:
-
资助金额:$19.14万
-
财政年份:2005
-
负责人:Laura P. Hale
-
依托单位:
Novel Oral Adjuvant for Dental Vaccines
-
批准号:6859474
-
项目类别:
-
资助金额:$19.25万
-
财政年份:2004
-
负责人:Laura P. Hale
-
依托单位:
Bromelain as a Biologically-Based Therapy for IBD
-
批准号:6947937
-
项目类别:
-
资助金额:$19.25万
-
财政年份:2004
-
负责人:Laura P. Hale
-
依托单位:
Bromelain as a Biologically-Based Therapy for IBD
-
批准号:6804195
-
项目类别:
-
资助金额:$19.25万
-
财政年份:2004
-
负责人:Laura P. Hale
-
依托单位:
Novel Oral Adjuvant for Dental Vaccines
-
批准号:6954192
-
项目类别:
-
资助金额:$19.25万
-
财政年份:2004
-
负责人:Laura P. Hale
-
依托单位:
MECHANISMS OF AGE RELATED THYMIC INVOLUTION
-
批准号:6077834
-
项目类别:
-
资助金额:$23.1万
-
财政年份:1998
-
负责人:Laura P. Hale
-
依托单位:
海外基金